The Chicago Entrepreneur

Pfizer delays its FDA application to expand its Covid vaccine to kids under 5 until April

Pfizer and BioNTech said they needed more data “because rates of infection and illness remain high in children of this age” due to the omicron variant.

Previous post Investing Club: Lots of Club stock earnings next week — here’s what Cramer hopes to hear
Next post Lilly’s COVID-19 treatment gets FDA’s emergency-use approval